Fig. 5.

Administration of ZT-1a at 2–4 weeks post-BCAS reduces immune cell infiltration into hemisphere and ChP. A Representative flow cytometric plots of CD11b⁺CD45^+hi or CD11b⁺CD45^+lo myeloid cells from cerebral hemisphere at 4 weeks post-BCAS surgery with the percentage of total number of CD11b⁺CD45^+hi or CD11b⁺CD45^+lo myeloid cells in the single cells. Data are mean ± SD (n = 7 mice). *P < 0.05, **p < 0.01. One Sample t-test. Unpaired t-test. B Percentage of anti-inflammation CD11b⁺CD45^+hi/CD206⁺ and CD11b⁺CD45^+lo/CD206⁺ cells. Data are mean ± SD (n = 7 mice). *p < 0.05. One Sample t-test. Unpaired t-test. C. The percentage of total number of CD3⁺ lymphocyte in the single cells and CD11b⁺CD45⁺/Ly6G⁺ neutrophils. Data are mean ± SD (n = 8 mice). *p < 0.05, **p < 0.01. One Sample t-test. Unpaired t-test. D Representative flow cytometric plots of CD11b⁺CD45^+hi or CD11b⁺CD45^+lo myeloid cells from the LVCP and the percentage in the single cells. Data are mean ± SD (n = 8–9 mice). One Sample t-test. Unpaired t-test. E Percentage of anti-inflammatory CD11b⁺CD45^+hi/CD206⁺ and CD11b⁺CD45^+lo/CD206⁺ cells. Data are mean ± SD (n = 8–9 mice), *p < 0.05, ** < 0.01. One Sample t-test. Unpaired t-test. F The percentage of total number of CD3⁺ lymphocyte and CD11b⁺CD45⁺/Ly6G⁺ neutrophils in the single cells. Data are mean ± SD (n = 8–9 mice), *p < 0.05. One Sample t-test. Unpaired t-test